Lv51
818 积分 2024-11-02 加入
Glp-1 Receptor Agonists Regulate the Progression of Diabetes Mellitus Complicated with Fatty Liver by Down-regulating the Expression of Genes Related to Lipid Metabolism
5小时前
已完结
Kori-tofu ameliorates obesity and steatotic liver disease through enhancing GLP-1 production in the ileum
5小时前
已完结
The management of hypothalamic obesity in craniopharyngioma
29天前
已完结
Hypothalamic syndrome
29天前
已完结
L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehicles
1个月前
已完结
High-performance supercapacitor of macroscopic graphene hydrogels by partial reduction and nitrogen doping of graphene oxide
1个月前
已完结
Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase
1个月前
已完结
A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
1个月前
已完结
TFEB-driven autophagy enhancement via a ROS-triggered NIR-II nanoplatform for targeted non-alcoholic fatty liver disease therapy
1个月前
已完结
Hepatic parenchymal cell and mitochondrial-targeted astaxanthin nanocarriers for relief of high fat diet-induced nonalcoholic fatty liver disease
1个月前
已完结
皖公网安备34019202002308
